Diagnos (TSE:ADK) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
DIAGNOS Inc., a Canadian AI-driven healthcare technology company, announced the successful re-election of its board directors and the re-appointment of its auditor following its recent shareholders meeting. Additionally, the company gained shareholder approval for an increase in the stock option plan by 2,000,000 shares, subject to TSX Venture acceptance.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.
